PMID- 16304626 OWN - NLM STAT- MEDLINE DCOM- 20060307 LR - 20131121 IS - 0021-9967 (Print) IS - 0021-9967 (Linking) VI - 493 IP - 4 DP - 2005 Dec 26 TI - Effects of intracerebroventricular losartan on angiotensin II-mediated pressor responses and c-fos expression in near-term ovine fetus. PG - 571-9 AB - The renin-angiotensin system plays an important role in cardiovascular control. Intracerebroventricular (i.c.v.) angiotensin (ANG) II causes a reliable pressor response in the fetus at 90% gestation. To determine the roles of brain AT1 and AT2 receptors in this response, the effects of the central AT1 and AT2 receptor antagonists losartan and PD123319 were investigated in chronically prepared near-term ovine fetuses. Losartan at 0.5 mg/kg (i.c.v.) abolished central ANG II-induced pressor responses. High-dose losartan (5 mg/kg, i.c.v.) showed a potentiation of the pressor response to i.c.v. ANG II, accompanied by bradycardia. Associated with the pressor responses, c-fos expression in the cardiovascular controlling areas was significantly different between the low and high doses of losartan. These areas included the subfornical organ, median preoptic nucleus, organum vasculosum of the lamina terminalis, and paraventricular nuclei in the forebrain, and the tractus solitarius nuclei, lateral parabrachial nuclei in the hindbrain. Low-dose losartan markedly reduced c-fos in these areas after i.c.v. ANG II, while the high-dose losartan together with ANG II elicited a much stronger FOS-immunoreactivity in these areas than that induced by i.c.v. ANG II alone. This is a novel finding, that c-fos expression in the brain can be both activated and inhibited under the same condition. Central ANG II-induced fetal pressor responses were not altered by PD123319 (0.8 mg/kg). These results indicate that i.c.v. losartan at a high and a low dose has strikingly different effects on central ANG II-induced pressor responses in fetuses at late gestation, and that the AT1 mechanism plays an important role in fetal cardiovascular regulation. CI - Copyright (c) 2005 Wiley-Liss, Inc. FAU - Shi, Lijun AU - Shi L AD - Research & Education Institute, Harbor-University of California, Los Angeles Medical Center, Torrance, California 90501, USA. FAU - Mao, Caiping AU - Mao C FAU - Thornton, Simon N AU - Thornton SN FAU - Sun, Wanping AU - Sun W FAU - Wu, Jiawei AU - Wu J FAU - Yao, Jiaming AU - Yao J FAU - Xu, Zhice AU - Xu Z LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Comp Neurol JT - The Journal of comparative neurology JID - 0406041 RN - 0 (Angiotensin II Type 1 Receptor Blockers) RN - 11128-99-7 (Angiotensin II) RN - JMS50MPO89 (Losartan) SB - IM MH - Analysis of Variance MH - Angiotensin II/administration & dosage/*drug effects/metabolism MH - Angiotensin II Type 1 Receptor Blockers/*administration & dosage MH - Animals MH - Blood Pressure/drug effects MH - Cardiovascular System/drug effects/embryology/metabolism MH - Dose-Response Relationship, Drug MH - Female MH - Fetus/drug effects MH - Genes, fos/*drug effects/physiology MH - Gestational Age MH - Homeostasis/drug effects/physiology MH - Injections, Intraventricular MH - Losartan/*administration & dosage MH - Pregnancy MH - Prosencephalon/*drug effects/embryology/metabolism MH - Sheep MH - Statistics, Nonparametric EDAT- 2005/11/24 09:00 MHDA- 2006/03/08 09:00 CRDT- 2005/11/24 09:00 PHST- 2005/11/24 09:00 [pubmed] PHST- 2006/03/08 09:00 [medline] PHST- 2005/11/24 09:00 [entrez] AID - 10.1002/cne.20802 [doi] PST - ppublish SO - J Comp Neurol. 2005 Dec 26;493(4):571-9. doi: 10.1002/cne.20802.